Get notified when VIR files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsVir Biotechnology reports Q1 2026 financial results
Filed May 6, 2026 · Period ending May 6, 2026 · ~1 min read
Key Changes
-
high
Company announced financial results for the quarter ended March 31, 2026 via press release. Specific revenue, earnings, and guidance figures are contained in the attached exhibit.
Item 2.02 verify on EDGAR → -
medium
Press release dated May 6, 2026 furnished as Exhibit 99.1. The 8-K filing itself contains no financial details beyond confirming the quarterly results announcement.
Item 9.01 verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (FNGR 10-Q) is open in full — no account needed.
Partner
Trade VIR commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify